Quote this publication Share Print

EFFENTORA

-
Opinions on drugs - Posted on May 21 2013

Reason for request

Inclusion on the list of medicines reimbursed by National Insurance and approved for hospital use.

-


Actual benefit

Important

The actual benefit of these medicines is substantial.


Improvement in actual benefit

V (absence)

In the absence of a study versus an active comparator, EFFENTORA provides no improvement in actual benefit (IAB V) compared to rapid-acting morphine drugs indicated in the management of breakthrough pain in adult patients who take morphine drugs to treat chronic cancer pain.


Contact Us

Évaluation des médicaments

See also

All our publication